Shopping Cart 0
Cart Subtotal
AED 0

Krka dd Novo Mesto (KRKG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Krka dd Novo Mesto (Krka) is a manufacturer and distributor of pharmaceutical products. The company provides prescription pharmaceuticals, non-prescription products, and animal health products. It offers prescription products for cardiovascular diseases, diseases of alimentary tract and metabolism, central nervous system, oncology, infections and other indications. Krka provides non-prescription products such as cold and cough products, analgesics, vitamin and mineral products, nasal products, and hair care products, among others. The company's animal health products include antimicrobials, disinfectants and others. It distributes its products across Slovenia, Austria, Bulgaria, Croatia, Germany, Lithuania, Italy, Spain, Sweden, the UK, Ireland, and Ukraine, among other countries. Krka is headquartered in Novo Mesto, Slovenia.

Krka dd Novo Mesto (KRKG)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Krka dd Novo Mesto, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Ningbo Menovo Pharma and Krka dd Novo Mesto Enter into Agreement 10

Krka dd Novo to Form Joint Venture 11

Equity Offering 12

Farmsintez Announces Private Placement Of Shares For USD 32.9 Million 12

Acquisition 13

Krka dd Novo to Acquire 51% Stake in Chinese Pharma Company 13

Krka dd Novo Mesto-Key Competitors 14

Krka dd Novo Mesto-Key Employees 15

Krka dd Novo Mesto-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 19

Financial Announcements 19

Jul 26, 2018: Krka presented its operating results for the half year ended 30 June 2018 19

May 23, 2018: Krka reports its operating results for the first quarter of 2018 23

Nov 16, 2017: Krka presented its operating results for the period January-September 2017 27

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34


List Of Figure

List of Figures

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Krka dd Novo Mesto, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Krka dd Novo Mesto, Deals By Therapy Area, 2012 to YTD 2018 8

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Ningbo Menovo Pharma and Krka dd Novo Mesto Enter into Agreement 10

Krka dd Novo to Form Joint Venture 11

Farmsintez Announces Private Placement Of Shares For USD 32.9 Million 12

Krka dd Novo to Acquire 51% Stake in Chinese Pharma Company 13

Krka dd Novo Mesto, Key Competitors 14

Krka dd Novo Mesto, Key Employees 15

Krka dd Novo Mesto, Subsidiaries 16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Krka dd Novo Mesto, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Krka dd Novo Mesto (Krka) is a manufacturer and distributor of pharmaceutical products. The company provides prescription pharmaceuticals, non-prescription products, and animal health products. It offers prescription products for cardiovascular diseases, diseases of alimentary tract and metabolism, central nervous system, oncology, infections and other indications. Krka provides non-prescription products such as cold and cough products, analgesics, vitamin and mineral products, nasal products, and hair care products, among others. The company's animal health products include antimicrobials, disinfectants and others. It distributes its products across Slovenia, Austria, Bulgaria, Croatia, Germany, Lithuania, Italy, Spain, Sweden, the UK, Ireland, and Ukraine, among other countries. Krka is headquartered in Novo Mesto, Slovenia.

Krka dd Novo Mesto (KRKG)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Krka dd Novo Mesto, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Ningbo Menovo Pharma and Krka dd Novo Mesto Enter into Agreement 10

Krka dd Novo to Form Joint Venture 11

Equity Offering 12

Farmsintez Announces Private Placement Of Shares For USD 32.9 Million 12

Acquisition 13

Krka dd Novo to Acquire 51% Stake in Chinese Pharma Company 13

Krka dd Novo Mesto-Key Competitors 14

Krka dd Novo Mesto-Key Employees 15

Krka dd Novo Mesto-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 19

Financial Announcements 19

Jul 26, 2018: Krka presented its operating results for the half year ended 30 June 2018 19

May 23, 2018: Krka reports its operating results for the first quarter of 2018 23

Nov 16, 2017: Krka presented its operating results for the period January-September 2017 27

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34


List Of Figure

List of Figures

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Krka dd Novo Mesto, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Krka dd Novo Mesto, Deals By Therapy Area, 2012 to YTD 2018 8

Krka dd Novo Mesto, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Ningbo Menovo Pharma and Krka dd Novo Mesto Enter into Agreement 10

Krka dd Novo to Form Joint Venture 11

Farmsintez Announces Private Placement Of Shares For USD 32.9 Million 12

Krka dd Novo to Acquire 51% Stake in Chinese Pharma Company 13

Krka dd Novo Mesto, Key Competitors 14

Krka dd Novo Mesto, Key Employees 15

Krka dd Novo Mesto, Subsidiaries 16

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Krka dd Novo Mesto, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat